PP2AT61ɛ Is an Inhibitor of MAP4K3 in Nutrient Signaling to mTOR

Yan, L., Mieulet, V., Burgess, D., Findlay, G. M., Sully, K., Procter, J., Goris, J., Janssens, V., Morrice, N. A. and Lamb, R. F. (2010) PP2AT61ɛ Is an Inhibitor of MAP4K3 in Nutrient Signaling to mTOR. Molecular Cell, 37(5), pp. 633-642. (doi: 10.1016/j.molcel.2010.01.031)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1016/j.molcel.2010.01.031

Abstract

The mammalian target of rapamycin (mTOR) pathway is activated by a variety of stimuli, including nutrients such as glucose and amino acids. The Ste20 family kinase MAP4K3 is regulated by amino acids and acts upstream of mTORC1. Here we investigate how MAP4K3 activity is regulated by amino acid sufficiency. We identify a transautophosphorylation site in the MAP4K3 kinase activation segment (Ser170) that is required for MAP4K3 activity and its activation of mTORC1 signaling. Following amino acid withdrawal, Ser170 is dephosphorylated via PP2A complexed to PR61 epsilon, a PP2A-targeting subunit. Inhibition of PR61 epsilon expression prevents MAP4K3 Ser170 dephosphorylation and impairs mTORC1 inhibition during amino acid withdrawal. We propose that during amino acid sufficiency Ser170-phosphorylated MAP4K3 activates mTORC1, but that upon amino acid restriction MAP4K3 preferentially interacts with PP2A(T61 epsilon), promoting dephosphorylation of Ser170, MAP4K3 inhibition, and, subsequently, inhibition of mTORC1 signaling.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Morrice, Dr Nicholas
Authors: Yan, L., Mieulet, V., Burgess, D., Findlay, G. M., Sully, K., Procter, J., Goris, J., Janssens, V., Morrice, N. A., and Lamb, R. F.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Molecular Cell
ISSN:1097-2765
Published Online:11 March 2010

University Staff: Request a correction | Enlighten Editors: Update this record